RedShift BioAnalytics is developing powerful new analytical tools for the R&D, life science and biopharmaceutical markets. Our measurement solutions combine tunable lasers, microfluidics, and analytical technologies to achieve revolutionary improvements in performance and measurement capabilities. RedShift BioAnalytics has developed a powerful new analytical technique called Microfluidic Modulation System, or MMS, that at long last enables the optical detection of very low levels of analytes in fluids. When applied to the detection of protein therapeutics, MMS provides the direct measurement, at the native concentrations, of a protein’s underlying biophysical structures. By harnessing the optical power and tunability of lasers, and the precision of fluidic modulation, MMS can rapidly measure a protein sample and its reference buffer in a single microfluidic cell.At RedShift, our mission is to provide customers with solutions that accelerate product discovery, development and manufacturing timelines while enabling dramatic improvements in performance, efficiency and cost.